CEO Jean Jacques Bienaime sold $2.8M of BioMarin Pharmaceutical Inc.

Sold$2,840,226

$94.67Price

30,000Shares

−4%Stake

What BMRN did after the filing

Prices for BMRN after this filing aren't in yet.

Traded Thu, May 11. Filed Mon, May 15, 4:58 PM ET, after the close. Not investment advice.